Sexual Functioning in Hyperprolactinemic Patients Treated With Cabergoline or Bromocriptine
This 2019 clinical trial compared the effects of cabergoline and bromocriptine on sexual functioning in hyperprolactinemic patients. The study included 39 women and 18 men initially treated with bromocriptine; due to poor tolerance, 19 women and 8 men switched to cabergoline. Over 16 weeks, cabergoline significantly improved sexual desire in